Company Who this page is about. 1 identity field
Location
La Jolla, CA
SEC filing record 1 source field
Fiscal year end
31 December
Inhibrx Biosciences, Inc. has filed 124 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 1-3 of 3 matching filings.

Per page
25
Current page
1
SC 13G File 005-94527

SC 13G

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94527

SC 13G filing

Filing date
07 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94527

SC 13G

Filing date
31 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .